A. Mantovani
Epidemiology · with Lonardo · 2018
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 35 citations into it
- Endocrinology, Diabetes and Metabolism — 24 citations into it
Whom A. Mantovani trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Targher (in Epidemiology)
Papers from A. Mantovani's perspective
Ordered by how strongly the researchers A. Mantovani trusts endorse each paper. Same corpus, a different order for every researcher.
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (Nature Reviews Gastroenterology &Hepatology)
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis (Journal of Gastroenterology and Hepatology)
- Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
- Association between Non-invasive Fibrosis Markers and Mortality among Adults with Non-alcoholic Fatty Liver Disease in the United States (Hepatology)
- Inflammation, metaflammation and immunometabolic disorders (Nature)
- Obesity induces a phenotypic switch in adipose tissue macrophage polarization. (Journal of Clinical Investigation)
- The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis (Hepatology)
- NAFLD: a multisystem disease. (Journal of Hepatology)
- Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. (Cell Metabolism)
- The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. (Journal of Clinical Investigation)
Their papers
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? (2018) — 662 citations